• 1
    Belin, D., J-D. Vassalli, C. Combepine, F. Godeau, Y. Nagamine, E. Reich, HP. Kocher, and RM. Duvoisin. 1985. Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. Eur. J. Biochem. 148, 225232.
  • 2
    Brand, N., M. Pitkovich, A. Krust, P. Chambon, H. de The, A. Marchio, P. Tiollais, and A. Delean. 1988. Identification of a second human retinoic acid receptor. Nature 332, 850853.
  • 3
    Chomzynski, P. and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 162, 156159.
  • 4
    Hu, L. and L. Gudas. 1990. Cyclic AMP analogs and retinoic acid influence the expression of retinoic acid receptor α, β and γ mRNAs in F9 teratocarcinoma cells. Mol. Cell. Biol. 10, 391396.
  • 5
    Iwai, SA., M. Kosaka, Y. Nishina, T. Sumi, M. Sakuda, and Y. Nishimune. 1993. Changes in Hox 1.6, c-jun, and Oct-3 gene expressions are associated with teratocarcinoma F9 cell differentiation in three different ways of induction. Exp. Cell Res. 205, 3943.
  • 6
    Knowles, BB., S. Pan, D. Solter, A. Linnenbach, C. Cruce, and K. Huebner. 1980. Expression of H-2, laminin and SV40T and TASA on differentiation of transformed murine teratocarcinoma cells. Nature 288, 615618.
  • 7
    Kosaka, M., Y. Nishina, M. Takeda, K. Matsumoto, and Y. Nishimune. 1991. Reversible effects of sodium butyrate on embryonal carcinoma F9 cells. Exp. Cell Res. 192, 4651.
  • 8
    Kruh, J. 1982. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell. Biochem. 42, 6282.
  • 9
    Levine, RA., J. Campisi, SY. Wang and LJ. Gudas. 1984. Butyrate inhibits the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells. Develop. Biol. 105, 443450.
  • 10
    Maniatis, T., EF. Fritsch, and J. Sambrook. 1982. Molecular Cloning:A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor , NY .
  • 11
    Martin, GR. 1980. Teratocarcinomas and mammalian embryogenesis. Science 209, 768776.
  • 12
    Martin, CA., LM. Ziegler, and JL, Napoli. 1990. Retinoic acid dibutyryl cAMP, and differentiation affect the expression of retinoic acid receptors in F9 cells. Proc. Natl. Acad. Sci. USA 87, 48044808.
  • 13
    Nicolas, JF., P. Avner, J. Gaillard J L. Guenet, H. Jacob, and F. Jacob. 1976. Cell lines derived from teratocarcinomas. Cancer Res. 36, 42244231.
  • 14
    Nishimune, Y., A. Kume, Y. Ogiso and A. Matsushiro. 1983. Induction of teratocarcinoma cell differentiation. Exp. Cell Res. 146, 439444.
  • 15
    Ogiso, Y., A. Kume, Y. Nishimune and A. Matsushiro. 1982. Reversible and irreversible stages in the transition of cell surface marker during the differentiation of pluripotent teratocarcinoma cell induced with retinoic acid. Exp. Cell Res. 137, 365372.
  • 16
    Prasad, KN., and PK. Sinha. 1976. Effects of sodium butyrate on mammalian cells in culture. In Vitro 12, 125132.
  • 17
    Rickles, RJ., AL. Darrow, and S. Strickland. 1988. Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation. J. Biol. Chem. 263, 15631569.
  • 18
    Rogers, MB., SC. Watloms, and LJ. Gudas. 1990. Gene expression in visceral endoderm: a comparison of mutant and wild-type F9 embryonal carcinoma cell differentiation. J. Cell Biol. 110, 17671777.
  • 19
    Sabbag KR., JE., Casanova, and LB., Grabel 1989. Plasminogen activator expression in F9 teratocarcinoma embryoid bodies and their endoderm derivatives. Development 106, 195201.
  • 20
    Sherman, MI., S. Strickland, and E. Reich. 1976. Differentiation of early mouse embryonic and teratocarcinoma cells in vitro: Plasminogen activator production Cancer Res. 36, 42084216.
  • 21
    Sherman, MI., MA. Eglitis, and R. Thomas. 1986. Reversible and irreversible effects of retinol upon the phenotypic properties of embryonal carcinoma cells. J. Embryol. Exp. Morph. 93, 179196.
  • 22
    Strickland, S. and V. Mahdavi. 1978. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15, 393403.
  • 23
    Strickland, S., KK. Smith, and KR. Marotti. 1980. Hormonal induction of differentiation in teratocarcinoma stem cells: Generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell 21, 347355.
  • 24
    Takeda, M., M. Kosaka, Y. Nishina, K. Sawada, K. Matsumoto, and Y. Nishimune. 1992. Teratocarcinoma F9 cells induced to differentiate with sodium butyrate produce both tissue-type and urokinase-type plasminogen activators. J. Cell. Biochem 49, 284289.
  • 25
    Tokunaga, K., H. Taniguchi, K. Yoda, M. Shimizu, and S. Sakiyama. 1986. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal β-actin mRNA. Nucleic Acids Res., 14, 2829.
  • 26
    Zelent, A., A. Krust, M. Petkovich, P. Kastner, and P. Chambon. 1989. Cloning of murine α- and β-retinoic acid receptors and a novel receptor predominantly expression in skin. Nature 339, 714717.